Jerome T Mettetal
6PUBLICATIONS
97CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 15, 2026
Targeting the chromatin modifying enzyme, KDM5C, enhances AKT inhibition response in ER+ breast cancer.Valentina Cutano, Shanade Dunn, Sungmi Park-Chouinard
|Mar 06, 2026
Capivasertib Combines with Trastuzumab Deruxtecan to Enhance Antitumor Activity in HER2-Positive and HER2-Low Tumors.Azadeh C Bashi, Theresa A Proia, Mandy Lawson
|Mar 27, 2024
Quantitative evaluation of trastuzumab deruxtecan pharmacokinetics and pharmacodynamics in mouse models of varying degrees of HER2 expression.Christina Vasalou, Theresa A Proia, Laura Kazlauskas
|Mar 08, 2024
Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations.Azadeh C Bashi, Elizabeth A Coker, Krishna C Bulusu
|Jan 17, 2024
Synergistic Drug Combinations Promote the Development of Resistance in Acute Myeloid Leukemia.Emily Mason-Osann, Amy E Pomeroy, Adam C Palmer
|May 01, 2020
Discovery and pharmacological characterization of AZD3229, a potent KIT/PDGFRα inhibitor for treatment of gastrointestinal stromal tumors.Erica Banks, Michael Grondine, Deepa Bhavsar
Pageof 1
Frequent Collaborators
3 joint publications
Simon T Barry
2 joint publications
Ultan McDermott
2 joint publications
Azadeh C Bashi
2 joint publications
Stephen Fawell
2 joint publications
Rhys DO Jones
1 joint publications
Michael Grondine
1 joint publications
Jason G Kettle
1 joint publications
Crystal Brown
1 joint publications
Teresa Collins
1 joint publications
Ross Overman
